Amyris to Announce Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 24, 2015
GlobeNewswire - Tue Feb 03, 7:01AM CST
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter ended December 31, 2014 after market close on Tuesday, February 24, 2015.
AMRS: 2.09 (+0.30)
Amyris to Launch Biopharma Platform
GlobeNewswire - Mon Feb 02, 9:05AM CST
Amyris, Inc. (Nasdaq:AMRS) announced today it plans to launch its µPharm(TM) (microPharm) Discovery and Production Platform. Amyris's µPharm platform provides the pharmaceutical industry with an integrated discovery and production process for therapeutic compounds for which a natural source is scarce or unavailable, or for which chemical synthesis is not cost-effective.
AMRS: 2.09 (+0.30)
3 Risks for My Favorite Biotech Stock in 2015
Maxx Chatsko, The Motley Fool - Motley Fool - Sat Jan 31, 7:50AM CST
Image source: Amyris. I recently labeled synthetic biology pioneer Amyris my favorite stock to buy in 2015 . That may catch a lot of people by surprise, but I believe investors have good reason to be optimistic that the company is finally...
IFF: 116.96 (+2.19), AMRS: 2.09 (+0.30)
British Invasion: Why is America Producing Fuel for This WWII Airplane?
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Jan 25, 10:05AM CST
This is the famous Spitfire that defended the skies over Great Britain during World War II. Can you guess what's in the fuel tank? Image source: Wikimedia Commons . No, the Spitfire wasn't fueled by traditional jet fuels. Instead, as with...
AMRS: 2.09 (+0.30), DD: 76.18 (-0.11), BP: 41.93 (+0.59), SZYM: 2.64 (+0.02)
Amyris to Enter the Industrial Cleaning Products Market
GlobeNewswire - Tue Jan 20, 7:12AM CST
Amyris, Inc. (Nasdaq:AMRS) announced today it plans to launch its first industrial cleaning products containing Amyris's Myralene(TM) renewable solvents through U.S. AutoForce and U.S. Lubricants, divisions of U.S. Venture, Inc.
AMRS: 2.09 (+0.30)
1 Big Oil Company That Sees a Future in Renewable Energy
Travis Hoium, The Motley Fool - Motley Fool - Sat Jan 17, 9:00AM CST
For decades, Big Oil companies have dominated energy with oil and natural gas. Competing energy sources like nuclear, biofuels, wind, and solar have popped up from time to time but long-term proved too expensive to compete with traditional energy, at...
AMRS: 2.09 (+0.30), TOT: 54.14 (-0.36), SPWR: 28.30 (+0.07)
Business chief bids adieu at Amyris
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 3:44PM CST
AMRS: 2.09 (+0.30)
This Technology Could Create Cheaper Marijuana Drugs
Maxx Chatsko, The Motley Fool - Motley Fool - Sat Jan 10, 9:04AM CST
Cannabinoids are moving into the 21st century by moving out of plants. Image source: Martijn/ Flickr There's a technology brewing that could make producing medical-grade cannabinoid compounds easier and cheaper than ever before. More efficient...
AMRS: 2.09 (+0.30), GWPH: 78.09 (+1.70), ABBV: 58.05 (+1.00), SNY: 49.42 (+0.82)
Amyris (AMRS) in Focus: Stock Falls 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 7:45AM CST
Amyris, trading at a one month volatile range of $2.14 to $2.65, fell over 7% in the last trading session
AMRS: 2.09 (+0.30), GRH: 0.75 (-0.04)
Why Amyris Is My Favorite Stock to Buy in 2015
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Dec 29, 11:00AM CST
While the field of synthetic biology has the potential to revolutionize industries ranging from health care to chemical manufacturing, it's been a rough road for investors in the first wave of companies. That's especially true for shareholders of ...
AMRS: 2.09 (+0.30), TOT: 54.14 (-0.36)
Falling Oil Prices Could Kill Environmentally-Friendly Jet Fuels
Reuben Brewer, The Motley Fool - Motley Fool - Sat Dec 20, 10:20AM CST
In JetBlue Airways ' third-quarter conference call, CEO David Barger explained that "we're obviously happy with the recent decline in fuel prices and expect to benefit from it." Fuel is JetBlue's largest expense, so oil prices falling from over...
AMRS: 2.09 (+0.30), JBLU: 16.83 (+0.09), ALK: 62.56 (-0.19), SZYM: 2.64 (+0.02)
This Gene Editing Technology Is About to Change Healthcare and GMOs Forever
Maxx Chatsko, The Motley Fool - Motley Fool - Tue Dec 16, 10:00AM CST
New technologies are tough to see coming from afar, but if you know where to look, you may be one step ahead. Image Source: Col Ford and Natasha de Vere/ Flickr . We have long used the same words ("coding", "sequence", and the like) when...
AMRS: 2.09 (+0.30), DOW: 49.44 (+0.29)
Amyris Renewable Jet Fuel Receives Regulatory Approval in Brazil
GlobeNewswire - Tue Dec 16, 7:00AM CST
Amyris, Inc. (Nasdaq:AMRS) welcomed the approval of its renewable jet fuel by Brazil's fuels regulator, ANP, clearing the way for the commercialization in Brazil of the Amyris renewable jet fuel in blends of up to 10 percent.
AMRS: 2.09 (+0.30)
Energy Investing: 4 Reasons We're Excited for 2015
Motley Fool Staff - Motley Fool - Sat Dec 13, 7:40AM CST
The sun is about to set on 2014, but that just means 2015 is right around the corner. Image source: Ryan Mcdonald/ Flickr . The S&P 500 is currently penciled in for a 14% gain (including dividends) for 2014. While that's a far cry from the 32%...
CXO: 117.11 (+1.51), AMRS: 2.09 (+0.30)
New finance chief at Amyris
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 8:15AM CST
AMRS: 2.09 (+0.30)
Why Amyris (AMRS) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 8:05AM CST
Amyris is one such stock that can be considered to drop as it has witnessed a significant price decline and has seen negative earnings estimate revisions
CQP: 31.16 (-0.51), AMRS: 2.09 (+0.30), ALDW: 17.45 (-0.06), GRH: 0.75 (-0.04)
Amyris Appoints Raffi Asadorian as Chief Financial Officer
GlobeNewswire - Wed Dec 03, 7:00AM CST
Amyris, Inc. (Nasdaq:AMRS) announced today the appointment of Raffi Asadorian as the Company's Chief Financial Officer, effective January 6, 2015. The Company's interim Chief Financial Officer, Paulo Diniz, will transition to a new role as Chairman of Amyris Brasil.
AMRS: 2.09 (+0.30)
Global Synthetic Biology Market 2014-2018: Market to Reach $5.6 Billion in 2018, Growing at a CAGR of 24%
M2 - Tue Dec 02, 10:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4g44dp/synthetic_biology) has announced the addition of the "Synthetic Biology Market by Tool, Technology, Application - Global Forecast to 2018" report to their offering. The global synthetic biology market is expected to reach $5,630.4 million in 2018 from $1,923.1 million in 2013, growing at a CAGR of 24% The synthetic biology market is highly competitive with a large number of players, including both big and small players, operating in this market. Synthetic biology is an emerging area of research and is broadly described as the design and construction of novel organisms or devices, artificial biological pathways, and the redesign of existing natural biological systems. The global synthetic biology market is segmented on the basis of tools, technologies, applications, and regions. On the basis of tools, the market is categorized into Xeno-nucleic acids, chassis organisms, oligonucleotides, enzymes, and cloning and assembly kits. The oligonucleotides segment is expected to account for the largest share of the synthetic biology market, by tool. However, the cloning and assembly kits segment is expected to grow at the fastest rate in the market, by tool. On the basis of technologies, the synthetic biology market is segmented into enabling and enabled technologies. Enabling technologies account is the largest and fastest-growing segment of the market, by technology. On the basis of applications, the synthetic biology market is segmented into environmental, medical, and industrial applications. Medical application is the largest (2013) and fastest-growing segment of the market, by application. The key factors that are expected to spur the growth of this market are increasing R&D expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising production of genetically modified crops, and incessantly rising funding in this field. However, ethical and social issues such as biosafety and biosecurity of synthetic biology are hindering the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Speaks 6 Market Overview 7 Industry Insights 8 Synthetic Biology Market, By Tool 9 Market, By Technology 10 Market, By Application 11 Synthetic Biology Market, By Geography 12 Competitive Landscape 13 Company Profiles - Amyris, Inc. - Dupont - Genscript USA, Inc. - Integrated Dna Technologies (IDT), Inc. - Intrexon Corporation - New England Biolabs, Inc. - Novozymes - Royal DSM N.V. - Synthetic Genomics, Inc. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/4g...ic_biology
AMRS: 2.09 (+0.30), XON: 39.30 (+1.05)
Can Biotech Save Natural Gas Producers Billions in Flaring Costs?
Maxx Chatsko, The Motley Fool - Motley Fool - Sat Nov 29, 3:00PM CST
A lack of pipelines in McKenzie County, N.D., forced the Orvis State well on the Evanson family farm to flare gas in 2013. Image source: Tim Evanson/ Flickr . The energy boom produced by shale formations across the United States has led to many...
CLR: 47.36 (+0.74), AMRS: 2.09 (+0.30), XON: 39.30 (+1.05)
Ethanol makers cheer as EPA punts on renewable fuel mandate decision
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 5:45PM CST
RGSE: 0.39 (-0.01), ARLP: 39.29 (+1.84), AMRS: 2.09 (+0.30), CNX: 33.60 (+0.87), JASO: 8.89 (-0.07), PVG: 6.44 (-0.07), REGI: 8.54 (-0.21), VLO: 58.60 (+2.05), ERX: 65.07 (+3.92), DQ: 21.04 (-0.21), SCTY: 57.60 (+0.44), DK: 32.60 (+0.11), PSX: 76.62 (+1.51), YGE: 2.25 (+0.02), PBF: 30.18 (+0.27), REX: 61.30 (-0.18), ASTI: 1.17 (+0.16), HSOL: 1.10 (-0.02), WLT: 1.09 (+0.05), CLD: 7.98 (+0.55), NRP: 7.86 (-0.45), EMKR: 5.40 (+0.15), FSLR: 48.84 (-0.58), ADM: 48.10 (+0.66), WLB: 28.91 (+0.29), OXF: 1.00 (-0.08), SZYM: 2.64 (+0.02), OIH: 36.16 (+0.87), HFC: 41.79 (+1.31), SPWR: 28.30 (+0.07), GEVO: 0.23 (+0.03), CSIQ: 28.84 (-0.30), AHGP: 53.10 (+1.92), ACI: 1.19 (+0.02), GPRE: 25.50 (-0.56), ALJ: 13.06 (+0.50), FF: 12.10 (+0.41), MEOH: 53.17 (+2.19), XLE: 82.04 (+1.70), VDE: 115.76 (+2.32), SCOK: 2.83 (-0.18), CDTI: 2.35 (+0.11), TSL: 10.65 (-0.01), WNR: 40.81 (+0.47), PVA: 7.14 (+0.24), ANR: 1.27 (+0.03), JKS: 21.90 (+0.03), YZC: 8.05 (-0.05), SOL: 1.40 (-0.07), CSUN: 1.90 (+0.25), BTU: 7.65 (+0.46), ALDW: 17.45 (-0.06), TSO: 81.92 (+0.50), MPC: 103.48 (+2.08), SUNE: 21.45 (+0.30), NTI: 21.72 (+0.02), ANDE: 45.11 (+0.71)